| Trial ID: | L0824 |
| Source ID: | NCT03260543
|
| Associated Drug: |
Ginseng Powder
|
| Title: |
A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Fermented Ginseng Powder on Liver Function
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver, Nonalcoholic
|
| Interventions: |
Dietary Supplement: fermented ginseng powder;Dietary Supplement: Placebo
|
| Outcome Measures: |
Changes of ALT(Alanine Transaminase)Changes of Liver function index;Changes of fatty liver grade;Changes of lipid metabolism index;Changes of total antioxidant capacity;Changes of imflammation index;Changes of Multidimensional Fatigue Scale
|
| Sponsor/Collaborators: |
Chonbuk National University Hospital
|
| Gender: |
All
|
| Age: |
19 Years70 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
90
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
|
| Start Date: |
23/03/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03260543
|
